Gosebruch Henry O
Reporting Owner SEC Filing List
CIK: 0001659625
| Form | Filer | Subject Company | Filing Agent | Date | Actions | ||
|---|---|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Acelyrin, Inc. | Acelyrin, Inc. /fa | 05/23/2025 | |||
| 4 | Statement of changes in beneficial owner... | Gosebruch Henry O | Acelyrin, Inc. /fa | 05/23/2025 | |||
| 144 | Filing for proposed sale of securities u... | Gosebruch Henry O | J.p. Morgan Securities Llc /fa | 03/12/2025 | |||
| 144 | Filing for proposed sale of securities u... | Neumora Therapeutics, Inc. | J.p. Morgan Securities Llc /fa | 03/12/2025 | |||
| 144 | Filing for proposed sale of securities u... | Gosebruch Henry O | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 02/18/2025 | |||
| 144 | Filing for proposed sale of securities u... | Neumora Therapeutics, Inc. | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 02/18/2025 | |||
| 4 | Statement of changes in beneficial owner... | Acelyrin, Inc. | 06/11/2024 | ||||
| 4 | Statement of changes in beneficial owner... | Gosebruch Henry O | Acelyrin, Inc. /fa | 06/11/2024 | |||
| 4 | Statement of changes in beneficial owner... | Gosebruch Henry O | Latham & Watkins Llp (filing Agent) /fa | 02/16/2024 | |||
| 4 | Statement of changes in beneficial owner... | Neumora Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 02/16/2024 | |||
| Load More | |||||||
Gosebruch Henry O 's Ownership Transactions
| Issuer | Filing Date |
Transaction Date |
Transaction Type |
Shares | Price | Total Amt | Shares Owned |
|---|
